Immunogenicity without Efficacy of an Adenoviral Tuberculosis Vaccine in a Stringent Mouse Model for Immunotherapy during Treatment

• S. Anisah Alyahya ,

  * E-mail: anisah.alyahya@gmail.com (SAA); JSadoff@its.jnj.com (JS); lamichhane@jhu.edu (GL)

  Affiliation Crucell Holland B.V., Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands

  ⨯
• Scott T. Nolan,

  Affiliation Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Cara M. R. Smith,

  Affiliation Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• William R. Bishai,

  Affiliations Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America, HHMI, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯
• Jerald Sadoff ,

  * E-mail: anisah.alyahya@gmail.com (SAA); JSadoff@its.jnj.com (JS); lamichhane@jhu.edu (GL)

  Affiliation Crucell Holland B.V., Janssen Infectious Diseases and Vaccines, Leiden, The Netherlands

  ⨯
• Gyanu Lamichhane

  * E-mail: anisah.alyahya@gmail.com (SAA); JSadoff@its.jnj.com (JS); lamichhane@jhu.edu (GL)

  Affiliation Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America

  ⨯